ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe

By Peter Loftus Of DOW JONES NEWSWIRES Drug maker Bristol-Myers Squibb Co. (BMY) said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas. Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in "various countries." The New York-based company said in a quarterly report filed Thursday with the SEC that it was cooperating with the government. A spokeswoman declined comment beyond the information in Thursday's SEC filing. Bristol-Myers, which sells the anti-clotting drug Plavix, previously disclosed that the SEC was investigating the activities of the company's units in Germany, concerning potential violations of the U.S. Foreign Corrupt Practices Act, or FCPA. U.S. authorities in recent years have stepped up enforcement of the FCPA, which bars U.S. companies from bribing foreign officials to obtain or retain business. Multinational drug and medical-device makers based in the U.S. have been among the targets of enforcement. Last year, Johnson & Johnson (JNJ) agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein. Other drug makers--including Pfizer Inc. (PFE), Merck & Co. (MRK) and Eli Lilly & Co. (LLY)--also have been the subjects of federal inquiries regarding the FCPA. -By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
07/07/201415:20:45Novartis Wins 'Breakthrough' Status for Leukemia Treatment
06/09/201417:14:14Merck to Buy Idenix for $3.85 Billion -- 7th Update
06/09/201416:58:36MARKET SNAPSHOT: U.S. Stocks Close Up; S&P 500, Dow At Record
06/09/201413:13:25Merck to Buy Idenix for $3.85 Billion -- 6th Update
06/09/201411:24:46Merck to Buy Idenix for $3.85 Billion -- 5th Update
06/09/201410:53:33MARKET SNAPSHOT: U.S. Stocks Edge Higher; S&P 500 Hits Record
06/09/201409:44:33Merck to Buy Idenix for $3.85 Billion -- 3rd Update
06/09/201409:44:31U.S. Hot Stocks: Hot Stocks to Watch
06/09/201409:00:14Merck to Buy Idenix for $3.85 Billion -- 2nd Update
06/09/201408:29:04Merck to Buy Idenix for $3.85 Billion -- Update
05/13/201407:40:16Merck to Sell Some Ophthalmology Assets
05/08/201410:10:37Merck Plans Phase 3 Trial for Drug for Bone Marrow Transplant...
05/06/201419:32:35Bayer to Buy Merck's Consumer Business for $14.2 Billion-8th...
05/06/201418:08:21MARKET SNAPSHOT: U.S. Stocks Fall; Nasdaq Leads Losses
05/06/201417:43:42Bayer to Buy Merck's Consumer Business for $14.2 Billion-7th...
05/06/201417:35:37Bayer to Buy Merck's Consumer Business for $14.2 Billion-6th...
05/06/201417:34:33EUROPE MARKETS: European Stocks Fall As OECD Calls For ECB Action
05/06/201417:33:18MARKET SNAPSHOT: U.S. Stocks Fall Amid Caution In Global Markets
05/06/201417:30:18Bayer Says It Remains Committed to Animal Health Unit
05/06/201417:26:19Bayer to Buy Merck's Consumer Business for $14.2 Billion-4th...

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad